Summary:
A phase IIIa 52 week study with 10 study visits and 1 phone call testing the effects of an oral investigational medication on blood sugars and weight.
Qualified Participants Must:
• Be 18 years of age or older
•
Have been diagnosed with type 2 diabetes for atleast 90 days
•
Be currently treated with one or two of the following: Metformin, sulphonylureas(such as glyburide, glimepiride, Glucotrol) SGLT-2 inhibitors(such as Farxiga, Invonkana or Jardiance) or thiazolidinediones(Actos, Avandia)
Qualified Participants May Receive:
Compensation for time and travel.